New perspectives in the diagnosis of systemic fungal infections

Annals of Medicine

Volumn 31, Issue 5, 1999, Pages 327-335

  Richardson, Malcolm D ^a   Kokki, Maarit H ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Diagnosis; Immunocompromised patients; Mycoses

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ANTIGEN DETECTION; ASPERGILLUS; CANDIDA; DIAGNOSTIC TEST; HUMAN; MORTALITY; MYCOSIS; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRULENCE;

EID: 0032705215     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899908995899     Document Type: Review

References (50)

1. Walsh TJ, Hiemenz JW, Anaissie E. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infect Dis Clin North Am 1996; 10: 365-400.
2. Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kähkölä T, et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients Bone Marrow Transplant 1997; 19: 801-8.
3. Ribaud P. Fungal infections and the cancer patient. Eur J Cancer 1997; 33 Suppl 4: S50-4.
4. Toren A, Or R, Ackerstein A, Nagler A. Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT). Bone Marrow Transplant 1997; 20: 67-9.
5. Tumbarello M, Tacconelli E, Pagano L, La Barbera ED, Morace G, Cauda R, et al. Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection. J Infect 1997; 34: 55-60.
6. Richardson MD, Kokki MH. Antifungal therapy in bone marrow failure. Br J Haematol 1998; 100: 619-28.
7. Lyytikainen O, Ruutu T, Volin L, Lautenschlager I, Jokipii L, Tiittanen L, et al. Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1057-9.
8. Denning DW, Evans EGV, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, et al. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur J Clin Microbiol Infect Dis 1997; 16: 424-36.
9. Yuen KY, Woo PCY, Ip MSM, Liang RH, Chiu EK, Siau H, et al. Stage-specific manifestations of mould infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears. Clin Infect Dis 1997; 25: 37-42.
10. LaRocco MT, Burgert SJ. Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev 1997; 10: 277-97.
11. Salonen J, Nikoskelainen J. Lethal infections in patients with hematological malignancies. Eur J Haematol 1993; 51: 102-8.
12. Latge J-P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-50.
13. Leung AN, Gosselin MV, Napper CH, Braun SG, Hu WW, Wong RM, et al. Pulmonary infections after bone marrow transplantation: clinical and radiographic findings. Radiology 1999; 210: 699-710.
14. Williamson ECM, Millar MR, Steward CG, Cornish JM, Foot ABM, Oakhill A, et al. Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 1999; 104: 560-8.
15. Patterson JE, Zidouh A, Miniter P, Andriole VT, Patterson TF. Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect Control Hosp Epidemiol 1997; 18: 104-8.
16. Wald A, Leisenring W, van Burik J-A, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-66.
17. Graham NJ, Muller NL, Miller RR, Shepherd JD. Intrathoracic complications following allogeneic bone marrow transplantation: CT findings. Radiology 1991; 181: 153-6.
18. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139-17.
19. Verweij PE, Donnelly JP, De Pauw BE, Meis JFGM. Prospects for the early diagnosis of invasive aspergillosis in the immunocompromised patient. Rev Med Microbiol 1996; 7: 105-13.
20. Rohlich P, Sarfati J, Mariani P, Duval P, Carol A, Saint-Martin C, et al. Prospective sandwich ELISA galactomannan assay: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996;15: 321-7.
21. Bretagne S, Marmorat-Khuong A, Kuentz M, Latge J-P, Bart-Delabesse E, Cordonnier C. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997; 35: 7-15.
22. Tabone MD, Vu-Thien H, Latge J-P, Landman-Parker J, Perez-Castignoli P, Moissenet D, et al. Value of galactomannan detection by sandwich enzyme-linked immunosorbant assay in the diagnosis and follow-up of invasive aspergillosis. Opportunistic Pathogens 1997; 9: 7-13.
23. Verweij PE, Dompeling EC, Donnelly JP, Schattenburg AVMB, Meis JFGM. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection 1997; 25: 86-9.
24. Patterson TF, Miniter P, Ryan JL, Andriole V. Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model. J Infect Dis 1988; 158: 415-22.
25. Hearn V, Pinel C, Blachier S, Ambroise-Thomas P, Grillot R. Antibody detection in invasive aspergillosis by analytical isoelectrofocusing and immunoblotting methods. J Clin Microbiol 1995; 33: 982-6.
26. Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M. Detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis. J Clin Microbiol 1996; 34: 2464-8.
27. Einsele H, Hebart H, Roller G, Loffler J, Rothenhofer I, Muller CA, et al. Detection and identification of fungal pathogens in blood by molecular probes. J Clin Microbiol 1997; 35: 1353-60.
28. Bretagne S, Costa JM, Bart-Delabesse E, Dhedin N, Rieux C, Cordonnier C. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 1998; 26: 1407-12.
29. Van Burik JA, Myerson D, Schreckhise RW, Bowden RA. Panfungal PCR assay for detection of fungal infection in human blood specimens. J Clin Microbiol 1998; 36: 1169-75.
30. Hopfer RL, Walden P, Setterquist S, Highsmith WE. Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. J Med Vet Mycol 1993; 31: 65-75.
31. Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol 1995; 33: 2913-9.
32. Obayashi T, Toshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, et al. Plasma (1->3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17-20.
33. Severens JL, Donnelly JP, Meis JFGM, De Vries Robbe PF, De Pauw BE, Verweij PE. Two strategies for managing invasive aspergillosis: a decision analysis. Clin Infect Dis 1997; 25: 1148-54.
34. Martino P, Girmenia C, Micozzi A, De Bernardis F, Boccanera M, Cassone A. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. Eur J Microbiol Infect Dis 1994; 13: 797-804.
35. Anttila V-J, Elonen E, Nordling S, Sivonen A, Ruutu T, Ruutu P. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis 1997; 24: 375-80.
36. Walsh TJ, Chanock SJ. Laboratory diagnosis of invasive candidiasis: a rationale for complementary use of culture- and nonculture-based detection systems. Int J Infect Dis 1997; 1 Suppl 1: S11-9.
37. Anttila V-J, Färkkila M, Jansson SE, Taavitsainen M, Kaukoranta-Tolvanen S-S, Nordling S, et al. Diagnostic laparoscopy in patients with acute leukemia and suspected hepatatic candidiasis. Eur J Clin Microbiol Infect Dis 1997; 16: 637-43.
38. Walsh TJ, Chanock SJ. Diagnosis of invasive fungal infections: advances in nonculture systems. Curr Clin Top Infect Dis 1998; 18: 101-53.
39. Lehtonen L, Anttila V-J, Ruutu T, Salonen J, Nikoskelainen J, Eerola E, et al. Diagnosis of disseminated candidiasis by measurement of urine D-arabinitol/L-arabinitol ratio. J Clin Microbiol 1996; 34: 2175-9.
40. Christensson B, Wiebe T, Pehrson C, Larsson L. Diagnosis of invasive candidiasis in neutropenic children with cancer by determination of D-arabinitol/L-arabinitol ratios in urine. J Clin Microbiol 1997; 35: 636-40.
41. Walsh TJ, Hathorn JW, Sobel JD, Merz WG, Sanchez V, Maret M, et al. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med 1991: 324: 1026-31.
42. Herent P, Stynen D, Hernando F, Fruit J, Poulain D. Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis. J Clin Microbiol 1992; 30: 2158-64.
43. Örmälä T, Korppi M, Katila M-L, Ojanen T, Perkkiö M. Prospective evaluation of Candida antigen and antibody assays for detection of Candida infections in children with malignant disease. Acta Paediatr 1995; 84: 183-7.
44. Garcia-Ruiz JC, del Carmen Arilla M, Regulez P, Quindos G, Alvarez A, Ponton J. Detection of antibodies to Candida albicans germ tubes for diagnosis and therapeutic monitoring of invasive candidiasis in patients with hematologic malignancies. J Clin Microbiol 1997; 35: 3284-7.
45. Mitsutake K, Kohno S, Miyazaki T, Miyazaki H, Maesaki S, Koga H. Detection of Candida enolase antibody in patients with candidiasis. J Clin Lab Anal 1994; 8: 207-10.
46. Van Deventer AJ, van Vliet HJ, Hop WC, Goessens WH. Diagnostic value of anti-Candida enolase antibodies. J Clin Microbiol 1994; 32: 17-23.
47. Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999; 37: 1510-7.
48. Morace G, Sanguinetti M, Posteraro M, Lo Cascio G, Fadda G. Identification of various medically important Candida species in clinical specimens using PCR-restriction enzyme analysis. J Clin Microbiol 1997; 35: 667-72.
49. Morace G, Pagano L, Sanguinetti M, Posteraro B, Mele L, Equitani F, et al. PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies. J Clin Microbiol 1999; 37: 1871-5.
50. Bougnoux M-E, Dupont C, Mateo J, Saulnier P, Faivre V, Payen D, et al. Serum is more suitable than whole blood for diagnosis of systemic candidiasis by nested PCR. J Clin Microbiol 1999; 37: 925-30.